vs
Side-by-side financial comparison of NEW JERSEY RESOURCES CORP (NJR) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $939.4M, roughly 1.6× NEW JERSEY RESOURCES CORP). NEW JERSEY RESOURCES CORP runs the higher net margin — 23.3% vs 4.4%, a 18.9% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs -33.0%). Over the past eight quarters, NEW JERSEY RESOURCES CORP's revenue compounded faster (111.6% CAGR vs 41.2%).
New Jersey Resources is an energy services holding company based in Wall Township, New Jersey. It is a Fortune 1000 company, and a member of the Forbes Platinum 400. New Jersey Natural Gas is its principal subsidiary.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
NJR vs ONC — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $939.4M | $1.5B |
| Net Profit | $218.9M | $66.5M |
| Gross Margin | — | 90.5% |
| Operating Margin | 32.0% | 12.4% |
| Net Margin | 23.3% | 4.4% |
| Revenue YoY | -33.0% | 32.8% |
| Net Profit YoY | 7.2% | 143.8% |
| EPS (diluted) | $2.16 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $939.4M | — | ||
| Q4 25 | $440.9M | $1.5B | ||
| Q3 25 | $188.3M | $1.4B | ||
| Q2 25 | $234.8M | $1.3B | ||
| Q1 25 | $569.2M | $1.1B | ||
| Q4 24 | $359.0M | $1.1B | ||
| Q3 24 | $265.7M | $1.0B | ||
| Q2 24 | $209.9M | $929.2M |
| Q1 26 | $218.9M | — | ||
| Q4 25 | $122.5M | $66.5M | ||
| Q3 25 | $15.1M | $124.8M | ||
| Q2 25 | $-15.1M | $94.3M | ||
| Q1 25 | $204.3M | $1.3M | ||
| Q4 24 | $131.3M | $-151.9M | ||
| Q3 24 | $91.1M | $-121.3M | ||
| Q2 24 | $-11.6M | $-120.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 90.5% | ||
| Q3 25 | — | 86.1% | ||
| Q2 25 | — | 87.5% | ||
| Q1 25 | — | 85.2% | ||
| Q4 24 | — | 85.8% | ||
| Q3 24 | — | 83.0% | ||
| Q2 24 | — | 85.1% |
| Q1 26 | 32.0% | — | ||
| Q4 25 | 40.6% | 12.4% | ||
| Q3 25 | 21.5% | 11.5% | ||
| Q2 25 | -0.5% | 6.7% | ||
| Q1 25 | 49.2% | 1.0% | ||
| Q4 24 | 52.8% | -7.0% | ||
| Q3 24 | 55.0% | -12.0% | ||
| Q2 24 | 2.8% | -11.5% |
| Q1 26 | 23.3% | — | ||
| Q4 25 | 27.8% | 4.4% | ||
| Q3 25 | 8.0% | 8.8% | ||
| Q2 25 | -6.4% | 7.2% | ||
| Q1 25 | 35.9% | 0.1% | ||
| Q4 24 | 36.6% | -13.5% | ||
| Q3 24 | 34.3% | -12.1% | ||
| Q2 24 | -5.5% | -13.0% |
| Q1 26 | $2.16 | — | ||
| Q4 25 | $1.21 | $0.05 | ||
| Q3 25 | $0.15 | $0.08 | ||
| Q2 25 | $-0.15 | $0.06 | ||
| Q1 25 | $2.02 | $0.00 | ||
| Q4 24 | $1.31 | $-0.10 | ||
| Q3 24 | $0.91 | $-0.09 | ||
| Q2 24 | $-0.12 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $4.5B |
| Total DebtLower is stronger | — | $836.4M |
| Stockholders' EquityBook value | — | $4.4B |
| Total Assets | — | $8.2B |
| Debt / EquityLower = less leverage | — | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $2.4M | $4.5B | ||
| Q3 25 | $591.0K | $4.0B | ||
| Q2 25 | $931.0K | $2.8B | ||
| Q1 25 | $83.7M | $2.5B | ||
| Q4 24 | $1.9M | $2.6B | ||
| Q3 24 | $1.0M | $2.7B | ||
| Q2 24 | $22.4M | $2.6B |
| Q1 26 | — | — | ||
| Q4 25 | $3.3B | $836.4M | ||
| Q3 25 | $3.3B | — | ||
| Q2 25 | $3.0B | — | ||
| Q1 25 | $3.0B | — | ||
| Q4 24 | $3.0B | — | ||
| Q3 24 | $2.9B | — | ||
| Q2 24 | $2.8B | — |
| Q1 26 | — | — | ||
| Q4 25 | $2.5B | $4.4B | ||
| Q3 25 | $2.4B | $4.1B | ||
| Q2 25 | $2.4B | $3.8B | ||
| Q1 25 | $2.5B | $3.5B | ||
| Q4 24 | $2.3B | $3.3B | ||
| Q3 24 | $2.2B | $3.4B | ||
| Q2 24 | $2.1B | $3.4B |
| Q1 26 | — | — | ||
| Q4 25 | $7.9B | $8.2B | ||
| Q3 25 | $7.6B | $7.6B | ||
| Q2 25 | $7.3B | $6.3B | ||
| Q1 25 | $7.3B | $5.8B | ||
| Q4 24 | $7.2B | $5.9B | ||
| Q3 24 | $7.0B | $5.8B | ||
| Q2 24 | $6.8B | $5.7B |
| Q1 26 | — | — | ||
| Q4 25 | 1.32× | 0.19× | ||
| Q3 25 | 1.36× | — | ||
| Q2 25 | 1.25× | — | ||
| Q1 25 | 1.20× | — | ||
| Q4 24 | 1.29× | — | ||
| Q3 24 | 1.31× | — | ||
| Q2 24 | 1.30× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $417.3M |
| Free Cash FlowOCF − Capex | — | $379.8M |
| FCF MarginFCF / Revenue | — | 25.4% |
| Capex IntensityCapex / Revenue | — | 2.5% |
| Cash ConversionOCF / Net Profit | — | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | — | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $26.7M | $417.3M | ||
| Q3 25 | $81.2M | $402.6M | ||
| Q2 25 | $-28.9M | $263.6M | ||
| Q1 25 | $423.0M | $44.1M | ||
| Q4 24 | $-9.0M | $75.2M | ||
| Q3 24 | $64.5M | $188.4M | ||
| Q2 24 | $24.3M | $-95.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | $379.8M | ||
| Q3 25 | — | $354.5M | ||
| Q2 25 | — | $219.8M | ||
| Q1 25 | — | $-12.3M | ||
| Q4 24 | — | $-17.3M | ||
| Q3 24 | — | $54.7M | ||
| Q2 24 | — | $-205.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 25.4% | ||
| Q3 25 | — | 25.1% | ||
| Q2 25 | — | 16.7% | ||
| Q1 25 | — | -1.1% | ||
| Q4 24 | — | -1.5% | ||
| Q3 24 | — | 5.5% | ||
| Q2 24 | — | -22.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.5% | ||
| Q3 25 | — | 3.4% | ||
| Q2 25 | — | 3.3% | ||
| Q1 25 | — | 5.0% | ||
| Q4 24 | — | 8.2% | ||
| Q3 24 | — | 13.3% | ||
| Q2 24 | — | 11.8% |
| Q1 26 | — | — | ||
| Q4 25 | 0.22× | 6.28× | ||
| Q3 25 | 5.39× | 3.22× | ||
| Q2 25 | — | 2.79× | ||
| Q1 25 | 2.07× | 34.71× | ||
| Q4 24 | -0.07× | — | ||
| Q3 24 | 0.71× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NJR
| Utility | $640.9M | 68% |
| Nonutility | $298.5M | 32% |
ONC
Segment breakdown not available.
